Manufacturer record
Technica Lab & Pharma Pvt. Ltd: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
3 batches manufactured by Technica Lab & Pharma Pvt. Ltd (Uttarakhand) were declared Not of Standard Quality between September 2022 and May 2024. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: TC- 060323, Metronidazole Extended Release Tablets USP 600 MG (exp Feb 2025). CDL Kolkata (CDSCO lab) found it not of standard quality: The sample does not conform to U.S.P with respect to the test of Dissolution. Listed in the May 2024 alert.
Records by type
3 records linked to Technica Lab & Pharma Pvt. Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Metronidazole Extended Release Tablets USP 600 MG | Batch TC- 060323Mfg Mar 2023 · Exp Feb 2025 | The sample does not conform to U.S.P with respect to the test of Dissolution.Dissolution | CDL KolkataCDSCO lab | May 2024 |
| Aceclofenac, Paracetamol & Serratiopeptidase Tablets (TENAC-SP Tablets) | Batch TT-011223Mfg Dec 2023 · Exp Nov 2025 | Description & Assay of SerratiopeptidaseAssay | CDL KolkataCDSCO lab | Mar 2024 |
| Flavosil -200 (Flavoxate Hydrochloride Tablets IP 200 mg) | Batch TT-041021Mfg Oct 2021 · Exp Sep 2023 | AssayAssay | CDL KolkataCDSCO lab | Sep 2022 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.